See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516479_2015_Insys_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516479, Insys Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 151,042,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 29,872,000 |
| 3 | remainder_Assets | 34,207,000 |
| 4 | LiabilitiesCurrent | 45,676,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,778,000 |
| 7 | CostOfGoodsAndServicesSold | 22,578,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 44,283,000 |
| 9 | ResearchAndDevelopmentExpense | 33,136,000 |
| 10 | remainder_Expenses | 84,304,000 |
| 11 | remainder_Revenues | 222,125,000 |
| 12 | remainder_NetIncome | 153,000 |
| 13 | remainder_ComprehensiveNetIncome | -24,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 215,121,000 |
| 1 | Liabilities | 49,454,000 |
| 2 | Expenses | 184,301,000 |
| 3 | Revenues | 222,125,000 |
| 4 | StockholdersEquity | 165,667,000 |
| 5 | NetIncome | 37,977,000 |
| 6 | ComprehensiveNetIncome | 37,965,000 |
| 7 | BaseVar | 335,589,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.02 |
| 9 | EconomicCapitalRatio | 3.70 |